Government of Romania Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2018
NCT03656484
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

National Institute of Infectious Diseases, Bucharest, Romania | Romanian National Authority for Scientific Research | Romanian National Authority for Scientific Research and Innovation (UEFISCIDI)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Periodontitis (Phase 2)

Periodontitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 5